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Summary The effect of 8-OH-DPAT, a 5-HT1A receptor agonist, on electrographic
activity during the kainic acid (KA)-induced status epilepticus (SE) was evaluated in
male Wistar rats. Electrographic (EEG) recordings from the ventral hippocampus and
the frontal cortex along with behavioral changes were evaluated in animals that
received KA administration (10 mg/kg, i.p.) 20 min after saline solution (control
group) or 8-OH-DPAT (1 mg/kg, s.c.) injection. Rats pretreated with 8-OH-DPAT
presented augmented latency for wet dog shakes (71%), generalized seizures (54%)
and behavioral SE (31%). 8-OH-DPAT delayed occurrence of the first KA-induced
paroxystic spikes (70%), increased latency to the EEG SE (39%) and decreased spike
frequency (35—43%) recorded from the frontal cortex, and increased the time
necessary for the high voltage EEG activity synchronization of the hippocampus
and the frontal cortex (125%). However, EEG ictal activity recorded in hippocampus
was not modified after 8-OH-DPAT pretreatment. These results indicate that 8-OH-
DPATreduces the EEG activity associated with the KA-induced SE in the frontal cortex,
but not the hippocampus, and suggest an inhibitory effect in the propagation of
epileptic seizures during the KA-induced SE.
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Status epilepticus (SE) is considered a neurological
emergency with a high degree of mortality.1 Twelve
to 30% of adult patients with temporal loben behalf of British Epilepsy Association.
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mental pathophysiology of SE involves a failure of
mechanisms that normally abort an isolated
seizure. This failure can arise from abnormally
persistent, excessive excitation or ineffective
recruitment of inhibition.1
Kainic acid (KA) produces SE of limbic seizures by
activation of glutamatergic receptors localized in
high density in the hippocampus.4—6 After systemic
injection of KA, it has been considered that the
hippocampus becomes the primary epileptic focus
and thereafter, the seizure activity propagates to
limbic and extralimbic brain areas including the
cortex.4,5,7,8
On the other hand, serotonin (5-HT) has been
involved in many cerebral disorders including epi-
lepsy.9 The activation of 5-HT1A receptors reduces
the in vitro epileptiform activity.10—14 The in
vivo administration of 5-HT1A receptor agonists,
such as 8-hydroxy-2-(di-n-propylamino)tetralin
(8-OH-DPAT), increases the after discharge thresh-
old, reduces the duration of partial seizures and
avoids the progression and generalization of par-
tial seizures induced by electrical kindling.15—17
8-OH-DPAT also decreases the number and dura-
tion of KA-induced hippocampal electrographic
seizures18 and increases the latency to the wet
dog shakes (WDS), generalized seizures (GS)
and occurrence of SE19 by activation of 5-HT1A
receptors.
The hippocampus and frontal cortex present a
high density of 5-HT1A receptors
20,21 and the activa-
tion of these receptors may differentially modulate
the participation of these brain areas in the gen-
eration and/or the propagation of epileptic activity
during KA-induced SE. The main goal of the present
study was to analyze how 8-OH-DPAT modulates the
KA-induced electrographic (EEG) seizures in the
hippocampus and frontal cortex, considered as
the epileptic focus and the area of seizure propaga-
tion, respectively.Methods
Subjects
Male Wistar rats, initially weighing 300 g, housed
at 22 8C and maintained on 12-h light/12-h dark
cycles were used in the present study. The animals
had free access to food and water. Procedures
involving the animals’ care were conducted in
agreement with the ‘‘Norma Oficial Mexicana’’
(NOM-062-ZOO-1999) and the Ethical Committee
of the ‘‘Centro de Investigacio´n y de Estudios
Avanzados’’ (Project 222/04).Experimental groups
Rats were anesthetized with a combination of Keta-
mine (100 mg/kg, i.p., Ketalin1 from Probiomed)
and Xylazine (20 mg/kg, i.m., Sigma). Then, a bipo-
lar electrode, consisting of two twisted strands of
stainless steel wire, insulated except at the cross-
section of their tips, was stereotaxically implanted
into the CA1 field of the right ventral hippocampus.
Coordinates in millimeters were as follows: 5.6
caudal to bregma, 4.6 from the midsagittal plane
and 8.0 from the skull surface.22 The electrode was
attached to male connector pins, which were
inserted into a connector strip. Stainless steel
screws were threaded into the cranium over the
right and left frontal cortex to fix the electrode
assembly and to record the EEG activity. The elec-
trode assembly was then fixed to the skull with
dental acrylic. The animals were kept individually
in plastic cages. One week after surgery, the rats
received saline solution (SS, 1 ml/kg, s.c.; n = 6) or
8-OH-DPAT (Sigma; 1 mg/kg, s.c.; n = 6) and 20 min
after, they received KA (10 mg/kg, i.p.) administra-
tion. EEG from the ventral hippocampus and frontal
cortex was recorded using a Grass model 8-18D EEG
machine. EEG was continuously obtained in basal
conditions (5 min before the SS or 8-OH-DPAT injec-
tion) and during 3 h after KA injection.
The following parameters on behavior and EEG
recording were obtained in accordance with pre-
vious studies18,19,23: (a) latency to the firstWDS, the
first behavioral GS and the behavioral SE, (b)
latency to the synchronization of high voltage
EEG activity between ventral hippocampus and
frontal cortex, (c) latency to the first EEG seizure
(high amplitude discharges lasting at least 3 s), (d)
latency to the establishment of electrographic SE
(continuous polyspike activity), (e) total time spent
in EEG seizure activity (cumulative seizure time
subtracting interictal time), and (f) spike frequency
(spikes per second). For spike evaluation, the
amplitude threshold was set at least three times
baseline.
The spike frequency was calculated every 15 min
during the first hour after KA administration and
then, every 30 min during the last 2 h. Correlations
between the spike frequency and time course were
obtained and then, the area under the curve (AUC)
was calculated by the trapezoidal rule.24 Prelimin-
ary experiments from our lab revealed that the time
course of the spike frequency consisted of two
phases as follows: (a) phase I (from 0 to 60 min after
KA) that comprises the onset and propagation of
ictal activity and (b) phase II (from 60 to 180 min
after KA), that represents the appearance and
maintenance of the SE.
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Table 1 Electrographic (EEG) parameters describing the effect of 8-OH-DPAT on kainic acid-induced status epilep-
ticus
Parameter Brain area Experimental group
SS + KA 8-OH-DPAT + KA
Latency (min)
Epileptiform spikes Hip 11.8  1.6 18.6  4.1
Cx 9.5  1.6 16.1  3.1 *
EEG seizure Hip 20.1  1.5 21.2  3.1
Cx 11.8  2.3 19.7  5.2
High voltage EEG activity synchronization Hip—Cx 16.3  2.3 37.3  6.1 **
EEG SE Hip 85.8  6.3 107.5  11.6
Cx 90.3  6 126  10.9 **
Total time spent in ictal EEG activity (min) Hip 131.4  5.8 97.5  12.5
Cx 124.8  14.8 118.7  16.3
Abbreviations: SS, saline solution; KA, kainic acid; SE, status epilepticus; Hip, ventral hippocampus; Cx, frontal cortex. Data are the
mean  S.E.M from 6 rats per group. *p < 0.05, **p < 0.01 compared with SS + KA group.At the end of the experiments, animals received
an overdose of pentobarbital and they were killed by
decapitation. The brain were removed and frozen
coronal sections (20 mm) were obtained and then
stained with cresyl violet to verify electrode implan-
tation by light microscopy.
Statistical analysis
Results were analyzed with an unpaired one-tailed
Student’s t test using GraphPad Prism softwareTM
Version 4.00 for Windows, and significances were
assigned at the 0.05 level.Figure 1 Electrographic recordings from ventral hippo-
campus (Hip) and frontal cortex (Cx) obtained from one
animal treated with saline solution (SS, upper panel) or 8-
OH-DPAT (1 mg/kg; lower panel), 180 min after the appli-
cation of kainic acid (KA). Notice that 8-OH-DPAT clearly
decreases the epileptic spike frequency and amplitude
induced by KA. Calibration bars: 1 s, 200 mV.Results
Administration of 10 mg/kg KA-induced WDS, GS and
SE in all animals (100%) pretreated with SS and 8-OH-
DPAT. Behavioral recordings revealed that rats pre-
treated with SS showed the first WDS at
23.8  3.3 min, the first GS at 72.2  5.9 min and
the SE at 96.1  6.9 min after KA injection. Animals
pretreated with 8-OH-DPAT displayed augmented
latency for the WDS (40.7  4.7 min, 71%; p <
0.01), the GS (110.9  7.1 min, 54%; p < 0.001)
and the SE (125.4  6.6 min, 31%; p < 0.01), when
compared with the KA control group.
The histological evaluation revealed that the
implanted electrodes were located in the CA1 field
of the ventral hippocampus and frontal cortex in all
rats. EEG recordings showed that rats pretreated
with 8-OH-DPAT displayed augmented latency to the
onset of epileptic spikes in the frontal cortex (70%),
but not in the hippocampus, in contrast to the
control animals. However, latency to the first EEG
seizure was not modified in the hippocampus or inthe frontal cortex. The latency for the KA-induced
high voltage EEG activity synchronization of the
hippocampus and the frontal cortex was signifi-
cantly increased (125%) in rats that received 8-
OH-DPAT. With regard to the latency to the EEG
SE, animals pretreated with 8-OH-DPAT showed
increased values for frontal cortex recordings
(39%), but no significant changes for hippocampus.
Nevertheless, the total time spent in EEG ictal
activity recorded in the hippocampus and the fron-
tal cortex was not significantly different after 8-OH-
DPAT pretreatment when compared with KA control
animals (Table 1).
Rats pretreated with 8-OH-DPAT showed reduced
KA-induced spike frequency in frontal cortex, as it
was observed on the decreased AUC for phase I (43%)
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Figure 2 Time-course of the spike frequency (top panels) recorded from hippocampus (Hip; right) and frontal cortex
(Cx; left), and the areas under the curve (AUC; bottom panels) during the initiation (phase I) and maintenance (phase II)
stages induced by kainic acid (KA) in rats pretreated with saline solution (SS; filled squares and bars) and 8-OH-DPAT
(1 mg/kg; open squares and bars). Values represent the mean  S.E.M obtained from 6 rats per group. *p < 0.01
compared with SS + KA group.and phase II (35%), when compared with SS pre-
treated animals. However, this effect was not
detected in EEG recordings from the hippocampus
(Figs. 1 and 2).Discussion
In the present study, the effects of 8-OH-DPAT, a 5-
HT1A receptor agonist, were evaluated in the beha-
vioral and EEG activity during the SE of limbic
seizures induced by KA. The results obtained indi-
cate that 8-OH-DPAT produces differential effects in
hippocampal and cortical epileptiform activity.
Systemic administration of 8-OH-DPAT increased
the latency to the behavioralWDS, GS and SE induced
by systemic KA injection. These effects correlate
with decreased KA-induced epileptic EEG activity.
The results obtained support a decreased severity
of KA-induced behavioral seizures after 8-OH-DPAT
treatment, such has been previously indicated.19
Previous studies have indicated that activation of
5-HT1A receptors from the hippocampus and the
frontal cortex reduces the EEG epileptiform activity
when induced in vitro10,12,13 and in vivo.15,16,18 The
present study demonstrates that systemic adminis-
tration of 8-OH-DPAT produces a delay in the EEGappearance of KA-induced first epileptiform spike
and SE in the frontal cortex, indicating a delay in
the onset of the convulsive action of KA. Additionally,
8-OH-DPATenhanced the time necessary to synchro-
nize the high voltage EEG activity between the hip-
pocampus and frontal cortex and decreased the
frequency of epileptic spikes recorded in the frontal
cortex. These results suggest an inhibitory action of
5-HT1A receptors in the frontal cortex and a protec-
tive effect of 8-OH-DPAT in this brain area against KA-
induced SE. In contrast, the KA-induced epileptic
activity from ventral hippocampus was not modified
by 8-OH-DPAT. The ventral hippocampus has elevated
susceptibility to epileptic activity, including a low
threshold to epileptiform afterdischarges25 and a
high susceptibility to the KA-induced excitatory
effects.26,27 It seems that the activation of 5-HT1A
receptors by 8-OH-DPAT is not sufficient tomodify the
KA-induced epileptiform activity and occurrence of
SE in this brain area.Given this evidence, it is possible
that the effects induced by 8-OH-DPATare not strong
enough to modify the epileptic activity in the epi-
leptic focus (ventral hippocampus), but do decrease
the epileptic activity in surrounding areas (frontal
cortex). This effect is relevant considering that neo-
cortical, but not hippocampal, electrographic
changes correlated with development of convulsive
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cortex is involved in the processes of seizure propa-
gation and synchronization.29—34 In fact, the neocor-
texmay exert contralateral inhibitory influences, via
the corpus callosum after systemic KA injection.35
The delayed appearance and reduced high voltage
EEG activity in the frontal cortex induced by 8-OH-
DPAT could be explained by a low synchronization
between the hippocampus and frontal cortex with a
consequent reduction in the epileptic activity. How-
ever, further experiments are necessary to investi-
gate this hypothesis.
In this study, the analysis of spike frequency
progression during the KA-induced SE revealed the
initiation and maintenance phases previously
described through the SE induced by pilocarpine
and self sustained-SE.36—39 In these models, the
initiation phase depends on the presence of external
stimulus (i.e., pilocarpine or electrical stimulation)
and is characterized by a progressive increase of the
spike frequency, whereas the maintenance phase
comprises seizures that occur after the external
stimulation is discontinued and involves mechan-
isms of maintenance of SE during which the spike
frequency becomes constant.37,40 The knowledge of
mechanisms associated with these two phases may
be important to investigate different pharmacolo-
gical profiles of the initiation and maintenance
phases of KA-induced SE. Our results revealed that
8-OH-DPAT decreased the spike frequency during
the initiation and maintenance phases in the frontal
cortex, an effect not detected in hippocampus. The
important consideration of these findings is a stron-
ger inhibitory effect of 8-OH-DPAT in the propaga-
tion of the epileptic activity in the cortex at the
beginning of KA-induced epileptiform activity.
In conclusion, 8-OH-DPATreduces the EEG activity
during the KA-induced SE in the frontal cortex, which
correlateswith a reduction in convulsive behavior, an
effect that may involve a reduced propagation but
not generation of epileptic activity. Since 8-OH-DPAT
was systemically applied,wecannot disregard that 5-
HT1A receptor activation in other brain areas, such as
the amygdala, thalamus and brain stem nuclei, or
serotonergic projections may be involved in the
effects found in the present study. These results
encourage the study of 5-HT1A receptor agonists
alone or in combination with classical antiepileptic
drugs as new therapeutic strategies to control SE.Acknowledgements
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